Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity,

Stephanie C Gordts1, Eline Van Craeyveld, Ilayaraja Muthuramu

  • 1Center for Molecular and Vascular Biology, Catholic University of Leuven, Leuven, Belgium.

Plos One
|October 12, 2012
PubMed

Insights

Gene transfer to lower cholesterol or raise HDL improved endothelial progenitor cell function, myocardial vascularity, and cardiac diastolic function in mice. These findings suggest potential therapeutic benefits for cardiovascular health.

Area of Science:

  • Cardiovascular Biology
  • Gene Therapy
  • Lipid Metabolism

Background:

  • Hypercholesterolemia and low HDL cholesterol are risk factors for coronary heart disease and heart failure.
  • The direct impact of lipid levels on myocardial function requires further investigation.
  • Endothelial progenitor cells (EPCs) play a crucial role in vascular health and repair.

Purpose of the Study:

  • To investigate if lipid-lowering or HDL-raising gene transfer enhances EPC number and function.
  • To determine if these interventions improve myocardial vascularity and cardiac function in mice.
  • To test the hypothesis that improved EPCs lead to better cardiac outcomes.

Main Methods:

  • Adenoviral vectors were used for gene transfer to lower LDL cholesterol (AdLDLr) or raise HDL (AdA-I) in LDL receptor-deficient mice.
  • EPC number and function (migration, adhesion) were assessed.
  • Myocardial capillary density and relative vascularity were quantified.
  • Cardiac diastolic function was evaluated using echocardiography.

Main Results:

  • AdLDLr transfer increased circulating EPCs by 2-fold and improved EPC function.
  • AdLDLr treatment led to a 28% increase in myocardial capillary density and 22% higher relative vascularity.
  • AdLDLr and AdA-I gene transfer significantly improved diastolic function parameters.
  • HDL-raising gene transfer also enhanced EPC number and function, and myocardial vascularity.

Conclusions:

  • Both lipid-lowering and HDL-raising gene transfer demonstrate beneficial effects on EPC biology.
  • These interventions positively impact myocardial vascularity and diastolic cardiac function.
  • Findings challenge the external validity of studies on myocardial biology in normocholesterolemic animal models.
Abstract